Innova Captab Ltd vs Syncom Formulations India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 12, 2026

Key Highlights

The Latest Trading Price of Innova Captab Ltd is ₹ 941 as of 12 Jun 15:30 . The P/E Ratio of Innova Captab Ltd changed from 27.2 on March 2024 to 27.9 on March 2026 . This represents a CAGR of 0.64% over 4 yearsThe P/E Ratio of Syncom Formulations (India) Ltd changed from 46.2 on March 2022 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Innova Captab Ltd changed from ₹ 2564 crore on March 2024 to ₹ 3933 crore on March 2026 . This represents a CAGR of 11.29% over 4 yearsThe Market Cap of Syncom Formulations (India) Ltd changed from ₹ 916.79 crore on March 2022 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Innova Captab Ltd for the Mar '26 is ₹ 449.37 crore as compare to the Dec '25 revenue of ₹ 451.95 crore. This represent the decline of -0.57% The revenue of Syncom Formulations (India) Ltd for the Mar '26 is ₹ 149.97 crore as compare to the Dec '25 revenue of ₹ 120.64 crore. This represent the growth of 24.31% The ebitda of Innova Captab Ltd for the Mar '26 is ₹ 66.66 crore as compare to the Dec '25 ebitda of ₹ 71.05 crore. This represent the decline of -6.18% The ebitda of Syncom Formulations (India) Ltd for the Mar '26 is ₹ 36.56 crore as compare to the Dec '25 ebitda of ₹ 26.71 crore. This represent the growth of 36.88% The net profit of Innova Captab Ltd changed from ₹ 29.48 crore to ₹ 38.08 crore over 8 quarters. This represents a CAGR of 13.65% The net profit of Syncom Formulations (India) Ltd changed from ₹ 7.63 crore to ₹ 25.17 crore over 8 quarters. This represents a CAGR of 81.63% The Dividend Payout of Innova Captab Ltd changed from 13.68 % on March 2026 to 13.68 % on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe Dividend Payout of Syncom Formulations (India) Ltd changed from 13.07 % on March 2022 to 0 % on March 2026 . This represents a CAGR of -100.00% over 5 years .

About Innova Captab Ltd

Innova Captab Limited was incorporated as Harun Health Care Private Limited', dated January 3, 2005, as a Private Limited Company at Mumbai.
Thereafter, the name of the Company was changed from Harun Health Care Private Limited' to Innova Captab Private Limited', and a fresh Certificate of Incorporation dated February 2, 2010, was issued by RoC to the Company.
Subsequently, Company got converted to a Public Company on July 12, 2018, and the name was changed to Innova Captab Limited', dated July 26, 2018. The Company is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain including research and development, manufacturing, drug distribution and marketing and exports.
Their business includes contract development and manufacturing organization (CDMO) business providing manufacturing services to Indian pharmaceutical companies, domestic branded generics business and an international branded generics business.

About Syncom Formulations (India) Ltd

Incorporated as a private limited Company in 1988, Syncom Formulations (India) Limited was converted into a public limited Company in June, 1992.
The Company in the Indian Pharmaceutical Industry represents synergistic combination of commitment and consistency.
Syncom possesses the manufacturing strength in its own manufacturing set-up at Pithampur, Madhya Pradesh. Established in 1988, Syncom plant is geared up with latest production machineries and maintains high quality standards.
Currently, the Company manufactures and markets more than 200 pharmaceutical formulations products in various dosage forms like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections & Dry Vial injections, Dry Syrups, Ointments and Inhalers. The company set up a manufacturing facility at Palghar, Thane to produce pharmaceutical formulations.

FAQs for the comparison of Innova Captab Ltd and Syncom Formulations (India) Ltd

Which company has a larger market capitalization, Innova Captab Ltd or Syncom Formulations (India) Ltd?

Market cap of Innova Captab Ltd is 5,443 Cr while Market cap of Syncom Formulations (India) Ltd is 1,304 Cr

What are the key factors driving the stock performance of Innova Captab Ltd and Syncom Formulations (India) Ltd?

The stock performance of Innova Captab Ltd and Syncom Formulations (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Innova Captab Ltd and Syncom Formulations (India) Ltd?

As of June 12, 2026, the Innova Captab Ltd stock price is INR ₹951.25. On the other hand, Syncom Formulations (India) Ltd stock price is INR ₹13.88.

How do dividend payouts of Innova Captab Ltd and Syncom Formulations (India) Ltd compare?

To compare the dividend payouts of Innova Captab Ltd and Syncom Formulations (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.